Variant report
Variant | nsv9891 |
---|---|
Chromosome Location | chr2:58951097-58953857 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:58938609..58940326-chr2:58950137..58952423,2 | K562 | blood: | |
2 | chr2:58944043..58945549-chr2:58950172..58951862,2 | K562 | blood: | |
3 | chr2:58935937..58937842-chr2:58949736..58951617,2 | K562 | blood: | |
4 | chr2:58945888..58951187-chr2:58955969..58958921,4 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs189473940 | chr2:58951098-58951099 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs993531 | chr2:58951109-58951110 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs552209964 | chr2:58951113-58951114 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs181858740 | chr2:58951147-58951148 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs2708149 | chr2:58951187-58951188 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs544948265 | chr2:58951218-58951219 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs185174177 | chr2:58951230-58951231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs188081414 | chr2:58951254-58951255 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549180881 | chr2:58951265-58951266 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs372564683 | chr2:58951297-58951298 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567506319 | chr2:58951314-58951315 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs17049707 | chr2:58951327-58951328 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs547128049 | chr2:58951333-58951334 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs181446754 | chr2:58951352-58951353 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs550697877 | chr2:58951389-58951390 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs539046819 | chr2:58951399-58951400 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs555907082 | chr2:58951402-58951403 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs557106392 | chr2:58951414-58951415 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs569963039 | chr2:58951420-58951421 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs112198296 | chr2:58951423-58951424 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs569519110 | chr2:58951457-58951458 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538919554 | chr2:58951534-58951535 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs536589281 | chr2:58951538-58951539 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs200971890 | chr2:58951580-58951581 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs147227095 | chr2:58951587-58951588 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558806034 | chr2:58951597-58951598 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573105134 | chr2:58951610-58951611 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs116587158 | chr2:58951626-58951627 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs77032580 | chr2:58951657-58951658 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs142083921 | chr2:58951695-58951696 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs186239221 | chr2:58951698-58951699 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs530813167 | chr2:58951765-58951766 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191880446 | chr2:58951768-58951769 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs375136653 | chr2:58951811-58951812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561028139 | chr2:58951826-58951827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs151156547 | chr2:58951840-58951841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554609947 | chr2:58951883-58951884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs547089367 | chr2:58951894-58951895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs571693608 | chr2:58951904-58951905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs532534302 | chr2:58951979-58951980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs17615638 | chr2:58952050-58952051 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs560115191 | chr2:58952052-58952053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs536500606 | chr2:58952106-58952107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs548482167 | chr2:58952171-58952172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs146612736 | chr2:58952172-58952173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs534143399 | chr2:58952181-58952182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs183255233 | chr2:58952185-58952186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs141364495 | chr2:58952212-58952213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs538392699 | chr2:58952226-58952227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs556909885 | chr2:58952252-58952253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21509527 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:58941200-58954600 | Weak transcription | Primary hematopoietic stem cells | blood |
2 | chr2:58948400-58955200 | Weak transcription | K562 | blood |
3 | chr2:58948400-58960000 | Weak transcription | H1 Cell Line | embryonic stem cell |
4 | chr2:58950200-58951200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr2:58951000-58951600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr2:58951200-58951800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
7 | chr2:58951600-58953000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr2:58951800-58952800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr2:58952800-58953200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
10 | chr2:58953000-58953200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr2:58953200-58953600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr2:58953200-58954200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
13 | chr2:58953600-58958000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |